Diverging acquired resistance evolutionary pathways in fusion-positive patients treated with tyrosine kinase inhibitors Meeting Abstract


Authors: Repetto, M.; Selenica, P.; Gazzo, A.; Richards, A. L.; Reis-Filho, J. S.; Jee, J.; Donoghue, M.; Weigelt, B.; Drilon, A. E.; Choudhury, N. J.
Abstract Title: Diverging acquired resistance evolutionary pathways in fusion-positive patients treated with tyrosine kinase inhibitors
Meeting Title: 2024 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 42
Issue: 16 Suppl.
Meeting Dates: 2024 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2024-06-01
Language: English
ACCESSION: WOS:001275557400624
PROVIDER: wos
DOI: 10.1200/JCO.2024.42.16_suppl.3015
Notes: Meeting Abstract: 3015 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon
  2. Britta Weigelt
    632 Weigelt
  3. Pier Selenica
    189 Selenica
  4. Andrea Maria Gazzo
    52 Gazzo
  5. Justin Jee
    53 Jee
  6. Matteo Repetto
    26 Repetto